Catalyst Pharmaceuticals (CPRX) Interest & Investment Income (2010 - 2014)
Catalyst Pharmaceuticals (CPRX) reported Interest & Investment Income of $5924.0 for Q3 2014, down 42.59% on a YoY basis from $10318.0 in Q3 2013, and down 62.37% quarter-over-quarter from $15744.0 in Q2 2014.
Catalyst Pharmaceuticals (CPRX) Interest & Investment Income (2010 - 2014) Analysis & Trends
Catalyst Pharmaceuticals has reported Interest & Investment Income for 5 years, with the latest figure at $5924.0 in Q3 2014.
- For the quarter ending Q3 2014, Interest & Investment Income fell 42.59% year-over-year to $5924.0; the trailing twelve-month figure through Sep 2014 stood at $76538.0 (up 119.55% YoY), and the FY2013 full-year result was $47421.0, up 216.65% from the prior year.
- Interest & Investment Income for Q3 2014 stood at $5924.0, down from $15744.0 in the prior quarter.
- The five-year high for Interest & Investment Income was $32760.0 in Q1 2014, with the low at $1317.0 in Q1 2012.
- Historically, Interest & Investment Income has averaged $7982.8 across 5 years, with a median of $4480.0 in 2010.
- Annual changes were most pronounced in 2012 — Interest & Investment Income plunged 58.79% — and 2013, when it jumped 524.62%.
- Catalyst Pharmaceuticals' Interest & Investment Income stood at $3418.0 in 2010, then plunged by 30.08% to $2390.0 in 2011, then soared by 299.58% to $9550.0 in 2012, then jumped by 131.52% to $22110.0 in 2013, then plunged by 73.21% to $5924.0 in 2014.
- The last three Interest & Investment Income figures came in at $5924.0 (Q3 2014), $15744.0 (Q2 2014), and $32760.0 (Q1 2014), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 597,319.59 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 305,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -14.79 Mn |
| 10 | Catalyst Pharmaceuticals | 3.84 Bn | 3.08 Bn | 134.92 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2014 | 5,924.00 |
| Jun 30, 2014 | 15,744.00 |
| Mar 31, 2014 | 32,760.00 |
| Dec 31, 2013 | 22,110.00 |
| Sep 30, 2013 | 10,318.00 |
| Jun 30, 2013 | 8,526.00 |
| Mar 31, 2013 | 6,467.00 |
| Dec 31, 2012 | 9,550.00 |
| Sep 30, 2012 | 2,744.00 |
| Jun 30, 2012 | 1,365.00 |
| Mar 31, 2012 | 1,317.00 |
| Dec 31, 2011 | 2,390.00 |
| Sep 30, 2011 | 3,169.00 |
| Jun 30, 2011 | 3,312.00 |
| Mar 31, 2011 | 2,114.00 |
| Dec 31, 2010 | 3,418.00 |
| Sep 30, 2010 | 4,480.00 |